As the CFO of the pharmaceutical giant has explained, a quarter of the 13 billion annual net sales of the company comes from its foreign markets.

As Mr. Miklós Nagy has also highlighted in the interview he gave to portfolio.hu, their key export markets are Ukraine and Romania, furthermore; their position has been strengthening intensively in the UK, in Turkey, and Russia, as well. The private limited company has been cooperating with EXIM since 2009, which has been covering the export risks of Béres by providing export credit insurance for their markets operating outside the European Union.

’In addition to managing our buyers’ default risks, it provides great support in examining the creditworthiness of our export partners and in determining customers’ credit limits, as well’ – tells Miklós Nagy.

The interview can be read here.